Torrent Pharmaceuticals has raised Rs 300 crore through issuance of Commercial Papers (CPs). Maturity of the said Commercial Papers will be on September 26, 2025. Tenure of the instrument is 92 days.
Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.